Cardiometabolic Comorbidities in Patients With Psoriasis: Focusing on Risk, Biological Therapy, and Pathogenesis
Psoriasis is a chronic inflammatory disease characterized by erythematous scaly plaques, accompanied by systemic damage that leads to the development of multiple comorbidities. In particular, the association between psoriasis and cardiometabolic comorbidities, including cardiovascular diseases (CVDs...
Saved in:
Main Authors: | Jiangluyi Cai (Author), Lian Cui (Author), Yu Wang (Author), Ying Li (Author), Xilin Zhang (Author), Yuling Shi (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Xiao-Yin-Fang Therapy Alleviates Psoriasis-like Skin Inflammation Through Suppressing γδT17 Cell Polarization
by: Xilin Zhang, et al.
Published: (2021) -
The Effects of Cardiometabolic Comorbidities on Biologic Treatment for Psoriasis with Respect to PASI Scores: A Qualitative Systematic Review
by: Osman A, et al.
Published: (2024) -
Pathogenesis of Psoriasis: Focus on Autoinflammation
by: Angelo Valerio Marzano, et al.
Published: (2018) -
CircRAB3B suppresses proliferation, motility, cell cycle progression and promotes the apoptosis of IL-22-induced keratinocytes depending on the regulation of miR-1228-3p/PTEN axis in psoriasis
by: Jiajing Lu, et al.
Published: (2021) -
Advancements in the Study of Biologic Agents in Comorbidities of Psoriasis: A Literature Review
by: Wang Y, et al.
Published: (2023)